HCA Healthcare, Inc. (HCA) Stock Forecast
HCA analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 26 analysts
- Price target
- $460.59 average of analyst targets
- Upside to target
- +0.4% from the latest close
- Next earnings
- October 27, 2026 EPS estimate $6.75
- 52-week range
- $361.32 – $545.13
HCA analyst ratings
26 analystsNumber of analysts at each rating.
HCA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
HCA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $6.63 | $5.83 | $7.35 | $6.96 | −4.7% | 20 |
| Current fiscal year (2026) | $29.48 | $28.62 | $30.41 | $28.21 | +4.5% | 23 |
| Next fiscal year (2027) | $31.99 | $30.16 | $34.04 | $29.48 | +8.6% | 23 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
HCA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $19.33B | $18.80B | $19.87B | +0.9% | 21 |
| Current fiscal year (2026) | $78.51B | $77.30B | $79.44B | +3.9% | 23 |
| Next fiscal year (2027) | $81.58B | $79.49B | $82.89B | +3.9% | 23 |
HCA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
HCA revenue: reported and forecast
HCA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $7.25 | $6.78 | $6.70 | $6.66 | $6.63 | −8.5% | 0 up · 3 down |
| Current fiscal year (2026) | $30.04 | $29.52 | $29.49 | $29.48 | $29.48 | −1.9% | 0 up · 1 down |
| Next fiscal year (2027) | $32.83 | $32.14 | $32.02 | $32.01 | $31.99 | −2.6% | 0 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
HCA earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; HCA beat in 10 of 12.
What analysts expect from HCA
26 analysts cover HCA Healthcare; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $460.59, 0.4% above the latest close of $458.84. Analysts expect earnings of $29.48 per share for 2026, +4.5% from a year earlier. For 2027 the average estimate is $31.99 per share on revenue of $81.6 billion. HCA Healthcare beat the EPS estimate in 10 of the last 12 quarters.
Related: HCA income statement, HCA key metrics, HCA chart. See the HCA stock overview for the latest quote and news.
HCA forecast FAQ
What is HCA Healthcare's price target?
The average analyst price target for HCA Healthcare is $460.59, 0.4% above the latest close of $458.84.
Is HCA Healthcare a buy, hold or sell?
Of 26 analysts covering HCA Healthcare, 14 rate it a strong buy, 1 a buy, 9 a hold, 1 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is HCA Healthcare's EPS forecast?
Analysts forecast $29.48 per share for 2026 (range $28.62 to $30.41); for 2027 the estimate is $31.99.
What is HCA Healthcare's revenue forecast?
The average revenue estimate for 2026 is $78.5 billion, growth of 3.9%; for 2027 it is $81.6 billion.
When does HCA Healthcare report earnings?
HCA Healthcare is expected to report results for the quarter ending September 30, 2026 on October 27, 2026 before the market opens; the EPS estimate is $6.75.
Does HCA Healthcare usually beat earnings estimates?
HCA Healthcare reported EPS at or above the analyst estimate in 10 of the last 12 quarters.